WeedMD and Privately Owned CannTx Life Sciences Sign Letter of Intent to Create a Cannabis Cultivation and Consumer-Centric Product Portfolio
WeedMD is pleased to announce it has signed a Letter of Intent to acquire all of the issued and outstanding shares of renowned craft cultivator CannTx Life Sciences Inc...
WeedMD Appoints Dynamic Leader Beth Carreon as New Chief Financial Officer
Formerly of Tilray Canada and Nestlé Canada, brings over 20 years of corporate finance, banking, M&A, and CPG experience
WeedMD Announces Closing of $17.25 Million Bought Deal Offering
WeedMD s pleased to confirm it has closed its previously announced bought deal short-form prospectus offering of 35,937,500 units (“Units”) at a price...
WeedMD’s Starseed Medicinal Announces the Release of Strain-Specific Products for PAX® ERA® Vaporizer
Patients may purchase PAX ERA pods in Pedro’s Sweet Sativa cultivar starting March 6th, 2021
WeedMD Announces Mary’s Medicinals Topicals Product Release in Canada
Acclaimed Mary’s Transdermal Compound, produced exclusively in Canada by WeedMD, with expected availability to Starseed Medicinal’s patients starting late February, 2021
WeedMD’s Saturday Cannabis Vaporizers Debut as the Top Seller in Ontario and Color Cannabis Brand Launches 15 gram Dried Flower Products
Terpene-infused Saturday Cannabis 510-thread vapes reach #1 status on Ontario Cannabis Store (OCS) during first month of sales, as product availability expands to retailers and other provinces
WeedMD Confirms its Color Cannabis Products Now in Stock in Quebec
Following the fulfilment of its first purchase order to Société québécoise du cannabis (SQDC), the Company and local partner ROSE LifeScience affirm Color Cannabis products now available
WeedMD’s Starseed Medicinal Signs Sixth LiUNA Local to Medical Cannabis Program and Expands Coverage to Manitoba
As the first Canadian union to actively provide comprehensive medical cannabis coverage, eligible members from LiUNA Local 1258 in Manitoba are now added to the program
WeedMD Announces the Development of New Cannabis 2.0 Products Featuring Hash, Live Resin and Rosin Extracts for Adult-Use Lineup
Expanded product portfolio using indoor and outdoor-grown, terpene-rich biomass to debut in Q2 2021
WeedMD Expands its Color Cannabis Brand into the Province of Quebec
Color Cannabis available to consumers in Quebec, one of Canada’s largest markets, via Société Québécoise du cannabis (SQDC) in partnership with local producer ROSE LifeScience.
WeedMD Launches Terpene-Infused Saturday Cannabis-branded Vaporization Products
One-gram 510-thread terpene-infused vaporization products shipping in Ontario by December 31st
WeedMD’s Color Cannabis Brand Selected as Top Sativa Flower for “Pedro’s Sweet Sativa” at Inaugural Kind Magazine Awards
First consumer-facing cannabis awards as voted by over 150 Canadian cannabis retail budtenders
WeedMD Debuts New Color Cannabis Cultivar Black Sugar Rose in Ontario and Launches Terpene-Labelled Profiles
Acclaimed strain released via the Ontario Cannabis Store with other provinces coming soon
WeedMD Appoints Seasoned HR Executive to Chief People Officer
Deborah Sikkema appointed Chief People Officer to lead the Company’s newly-integrated talent, culture and organizational development initiatives
WeedMD Appoints Veteran Finance Executive to its Board of Directors
Distinguished business leader and former Deloitte partner Luciano (Lu) Cacioppo appointed as an independent director and chair of Company’s Audit Committee
WeedMD Announces Cannabis 2.0 Supply Partnership with PAX LABS®
Pods for PAX® ERA® and ERA PRO™ cannabis vaporizers to be filled and sold by Company using its terpene-rich biomass and co-marketed under Color Cannabis and Starseed brands
WeedMD Reports Second Quarter 2020 Financial Results and Closes $30 Million Credit Facility with LiUNA Pension Fund
Management to host conference call on Thursday, October 1st, 2020 at 10:00 a.m. Eastern Time
WeedMD Closes Definitive Agreement for $30 Million Credit Facility with LiUNA Pension Fund
Non-dilutive financing to fund continued growth and accelerate sales of Color Cannabis adult-use products and Starseed’s unique medical service offerings to payor groups and patients
WeedMD Enters into Binding Term Sheet for $30 Million Credit Facility with LiUNA Pension Fund and Changes Filing Date of Second Quarter 2020 Financials to September 30, 2020
Non-dilutive financing to fund continued growth including accelerating sales of Color Cannabis adult-use products and Starseed’s unique medical service offerings to payor groups and patients
WeedMD and Starseed Medicinal Launch Combined Medical Sales Marketplace with Expanded Cannabis Product Offerings
Medical cannabis dried flower, oils, vaporization products and softgel capsules now available to all registered patients under one simplified online sales system